注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Biophytis SA(原名:Institut Biophytis Sas),是一家法國醫療保健公司。該公司是一家生物技術實體,專門開髮用於治療衰老相關疾病的候選藥物。它的兩個產品涉及肌肉減少症(肌肉功能喪失)和年齡相關性黃斑變性(ARMD)。Biophytis SA同時在美國和國內市場從事其候選藥物的臨床和監管開發,如Sarconeos(BIO101)和Macuneos(BIO201)。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Roger A. Fielding | - | 2016 | Member of Scientific Advisory Board |
Jose-Alain Sahel | - | - | Member of Scientific Advisory Board |
Nadine Coulm | 61 | 2015 | Independent Director |
Jean Mariani | 74 | 2016 | Chairman of Scientific Advisory Board & Director |
Thomas Voit | - | 2017 | Member of Scientific Advisory Board |
Stanislas Veillet | 59 | 2015 | Chairman of the Board & CEO |
Rene Lafont | 78 | 2011 | Scientific Advisor & Member of Scientific Advisory Board |
Yann Meunier | - | 2023 | Member of Scientific Advisory Board |
Claude Allary | 69 | 2021 | Independent Director |
Dennis Villareal | - | 2024 | Member of Scientific Advisory Board |
Bernard Levy | - | 2023 | Member of Scientific Advisory Board |
Francisco Guarner | - | 2024 | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核